DEPTOR is a microRNA-155 target regulating migration and cytokine production in diffuse large B-cell lymphoma cells

被引:10
|
作者
Jablonska, Ewa [1 ]
Bialopiotrowicz, Emilia [1 ]
Szydlowski, Maciej [1 ]
Prochorec-Sobieszek, Monika [2 ]
Juszczynski, Przemyslaw [1 ]
Szumera-Cieckiewicz, Anna [2 ]
机构
[1] Inst Hematol & Transfus Med, Dept Expt Hematol, Indiry Gandhi 14, PL-02776 Warsaw, Poland
[2] Inst Hematol & Transfus Med, Dept Diagnost Hematol, Indiry Gandhi 14, PL-02776 Warsaw, Poland
关键词
NF-KAPPA-B; DEATH GENE BNIP3; C-CBL; UBIQUITIN LIGASES; MIR-155; EXPRESSION; ACTIVATION; SURVIVAL; SYK; INHIBITION;
D O I
10.1016/j.exphem.2020.07.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
MicroRNA-155 (MiR-155) is involved in normal B-cell development and lymphomagen-esis, affecting cell differentiation, motility, and intracellular signaling. In this study, we searched for new targets of MiR-155 potentially involved in deregulation of the B-cell receptor pathway (BCR) in diffuse large B-c ell lymphoma (DLBCL). We report that MiR-155 represses DEPTOR (an mTOR phosphatase) and c-CBL (SYK ubiquitin E3 ligase) through direct 30-untranslated region interactions. In primary DLBCLs, MiR-155 exhibits a reciprocal expression pattern with DEPTOR and c-CBL. Inhibition of MiR-155 decreased expression of NFKB target genes and sensitized DLBCL cells to ibrutinib, confirming the role of MiR-155 in the modulation of BCR signaling. As the function of DEPTOR in DLBCLs has never been addressed, we first evaluated its expression in a series of 76 newly diagnosed DLBCL patients. DEPTOR protein expres-sion was markedly lower in more aggressive nongerminal center-like (non-GCB) DLBCLs than in GCB tumors. In cell line models, inhibition of DEPTOR expression favored the migration of DLBCL cells toward the CXCL12 gradient. Finally, loss or gain of DEPTOR modulated the expression of specific pro-inflammatory cytokines and chemokines. We thus identified DEPTOR as a new MiR-155 target that is differentially expressed between GCB-and non-GCB-type DLBCLs and modulates cell migration and cytokine expression in DLBCL cells. (C) 2020 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:56 / +
页数:14
相关论文
共 50 条
  • [21] Diffuse large B-cell lymphoma
    Li, Shaoying
    Young, Ken H.
    Medeiros, L. Jeffrey
    PATHOLOGY, 2018, 50 (01) : 74 - 87
  • [22] Diffuse large B-cell lymphoma
    Hunt, Kristin E.
    Reichard, Kaaren K.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2008, 132 (01) : 118 - 124
  • [23] Diffuse large B-cell lymphoma
    Fuchs, David
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2019, 12 (01) : 7 - 11
  • [24] Diffuse large B-cell lymphoma
    Salles, G.
    EJC SUPPLEMENTS, 2010, 8 (04): : 8 - 9
  • [25] Diffuse large B-cell lymphoma
    Ng, Andrea K.
    SEMINARS IN RADIATION ONCOLOGY, 2007, 17 (03) : 169 - 175
  • [26] Diffuse large B-cell lymphoma
    Martelli, Maurizio
    Ferreri, Andres J. M.
    Agostinelli, Claudio
    Di Rocco, Alice
    Pfreundschuh, Michael
    Pileri, Stefano A.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 87 (02) : 146 - 171
  • [27] Diffuse large B-cell lymphoma
    Decool, Gauthier
    Theves, Floriane
    HEMATOLOGIE, 2018, 24 : 35 - 40
  • [28] Diffuse Large B-Cell Lymphoma
    Lang, Raynell
    Gill, M. John
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (23): : 2261 - 2262
  • [29] Diffuse Large B-Cell Lymphoma
    Friedberg, Jonathan W.
    Fisher, Richard I.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2008, 22 (05) : 941 - +
  • [30] Diffuse large B-cell lymphoma
    Shahi, Parham Khosravi
    Manga, Gumersindo Perez
    MEDICINA CLINICA, 2006, 127 (01): : 17 - 21